Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
NCT: NCT05007925 · COMPLETED
NCT IDNCT05007925
StatusCOMPLETED
Start Date2021-11-18
Completion2026-03-27
Brief Summary
To assess the continued safety, effectiveness, and optimal clinical use of the Shockwave Medical Peripheral IVL System for the treatment of calcified, stenotic BTK arteries. Post-market, prospective , multi-center, single-arm study.
Frequently Asked Questions
What is Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System?
Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System is a clinical trial registered under NCT05007925. Current status: COMPLETED.
What is the status of NCT05007925?
The current status of NCT05007925 (Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System) is: COMPLETED.
When did Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System start?
Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System started on 2021-11-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.